CIK: 1539215 - Address: C/o Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD 20850
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/5/25 16:37
2/4/25
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBhatt Padmanabh P.MDOSVP of IS.d-37639.700-9-4810D
1/29/25 17:04
1/27/25
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBhatt Padmanabh P.MDOSVP of IS.dm-13039.620-3-2410D
12/4/24 16:36
12/3/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBhatt Padmanabh P.MDOSVP of IS.d-78836.680-21-6910D
3/25/24 17:00
3/21/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBhatt Padmanabh P.MDOSVP of IS.d-51235.310-14-639D
3/22/24 17:00
3/20/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBhatt Padmanabh P.MDOSVP of IS.d-1435.3100-49D
3/21/24 17:01
3/19/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBhatt Padmanabh P.MDOSVP of IS.d-43735.310-12-599D
3/15/24 18:39
3/13/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBhatt Padmanabh P.MDOSVP of IS.d-2,10433.740-62-889D
3/14/24 17:00
3/12/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBhatt Padmanabh P.MDOSVP of IS.d-12832.990-4-319D
2/28/24 17:01
2/26/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBhatt Padmanabh P.MDOSVP of IS.d-15130.210-5-379D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact